Wang Xiaoliang, Liu Zhipeng, Wang Kai, Wang Zhaowen, Sun Xing, Zhong Lin, Deng Guilong, Song Guohe, Sun Baining, Peng Zhihai, Liu Wanqing
Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai China.
Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN USA.
Front Genet. 2016 Aug 2;7:140. doi: 10.3389/fgene.2016.00140. eCollection 2016.
Recent genome-wide association studies have identified that variants in or near PNPLA3, NCAN, GCKR, LYPLAL1, and TM6SF2 are significantly associated with non-alcoholic fatty liver disease (NAFLD) in multiple ethnic groups. Studies on their impact on NAFLD in Han Chinese are still limited. In this study, we examined the relevance of these variants to NAFLD in a community-based Han Chinese population and further explored their potential joint effect on NAFLD. Six single nucleotide polymorphisms (SNPs) (PNPLA3 rs738409, rs2294918, NCAN rs2228603, GCKR rs780094, LYPLAL1 rs12137855, and TM6SF2 rs58542926) previously identified in genome-wide analyses, to be associated with NAFLD were genotyped in 384 NAFLD patients and 384 age- and gender-matched healthy controls. We found two out of the six polymorphisms, PNPLA3 rs738409 (OR = 1.52, 95%CI: 1.19-1.96; P = 0.00087) and TM6SF2 rs58542926 (OR = 2.11, 95%CI: 1.34-3.39; P = 0.0016) are independently associated with NAFLD after adjustment for the effects of age, gender, and BMI. Our analysis further demonstrated the strong additive effects of the risk alleles of PNPLA3 and TM6SF2 with an overall significance between the number of risk alleles and NAFLD (OR = 1.64, 95%CI: 1.34-2.01; P = 1.4 × 10(-6)). The OR for NAFLD increased in an additive manner, with an average increase in OR of 1.52 per additional risk allele. Our results confirmed that the PNPLA3 and TM6SF2 variants were the most significant risk alleles for NAFLD in Chinese population. Therefore, genotyping these two genetic risk factors may help identify individuals with the highest risk of NAFLD.
近期全基因组关联研究已确定,PNPLA3、NCAN、GCKR、LYPLAL1和TM6SF2基因内部或附近的变异与多个种族群体的非酒精性脂肪性肝病(NAFLD)显著相关。关于这些变异对汉族人群NAFLD影响的研究仍然有限。在本研究中,我们在一个基于社区的汉族人群中研究了这些变异与NAFLD的相关性,并进一步探讨了它们对NAFLD的潜在联合作用。对先前在全基因组分析中确定与NAFLD相关的6个单核苷酸多态性(SNP)(PNPLA3 rs738409、rs2294918,NCAN rs2228603,GCKR rs780094,LYPLAL1 rs12137855和TM6SF2 rs58542926)在384例NAFLD患者和384例年龄及性别匹配的健康对照中进行基因分型。我们发现,在调整年龄、性别和BMI的影响后,6个多态性中的2个,即PNPLA3 rs738409(比值比[OR]=1.52,95%置信区间[CI]:1.19 - 1.96;P = 0.00087)和TM6SF2 rs58542926(OR = 2.11,95%CI:1.34 - 3.39;P = 0.0016)与NAFLD独立相关。我们的分析进一步证明了PNPLA3和TM6SF2风险等位基因的强相加效应,风险等位基因数量与NAFLD之间具有总体显著性(OR = 1.64,95%CI:1.34 - 2.01;P = 1.4×10⁻⁶)。NAFLD的OR以相加方式增加,每增加一个风险等位基因,OR平均增加1.52。我们的结果证实,PNPLA3和TM6SF2变异是中国人群中NAFLD最显著的风险等位基因。因此,对这两个遗传风险因素进行基因分型可能有助于识别NAFLD风险最高的个体。